PH
Par Health, Inc.
SEC filingPharmaceuticals · St. Louis, MO
Amount raised$763Msold at filing
Total offering$763M
Investors in the raise234count reported to the SEC
FiledNov 25, 2025first sale Nov 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Teresa SanzotteraExecutive Officer
Jake LongeneckerExecutive Officer
Jeffrey WiegersExecutive Officer
Scott SimsExecutive Officer
Mick McGuinnessExecutive Officer
Kass HarroldExecutive Officer
Matthew StoberDirector
Michael HeffernanDirector
Joshua MurrayDirector
Stephen WelchExecutive Officer, Director
Jonathan ZinmanDirector
Matthew MalettaExecutive Officer
Executive officers, directors and promoters as listed on the Form D.